Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TARS | Common Stock | Options Exercise | $0 | +10.3K | +147.01% | $0.00 | 17.2K | Nov 29, 2022 | Direct | F1, F2 |
transaction | TARS | Common Stock | Sale | -$19.5K | -1.18K | -6.87% | $16.50 | 16K | Nov 30, 2022 | Direct | F3 |
transaction | TARS | Common Stock | Sale | -$19.5K | -1.16K | -7.26% | $16.75 | 14.9K | Dec 1, 2022 | Direct | F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | TARS | Restricted Stock Units | Options Exercise | $0 | -10.3K | -30% | $0.00 | 23.9K | Nov 29, 2022 | Common Stock | 10.3K | Direct | F4 |
Id | Content |
---|---|
F1 | The Reporting Person received restricted stock units ("RSUs") which represent a contingent right to receive one share of Issuer's Common Stock for each RSU. This reported transaction represents the settlement of RSUs vested as of November 29, 2022. |
F2 | Includes 862 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021, and includes 1,111 shares acquired under the Issuer's employee stock purchase plan on June 30, 2022. |
F3 | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. |
F4 | RSU granted under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. The RSUs will vest 30% on November 29, 2022, and 70% on November 29, 2023, subject to the Reporting Person's continuous service. |